146 related articles for article (PubMed ID: 24292090)
1. Proteomic analysis of the proteins that are associated with the resistance to paclitaxel in human breast cancer cells.
Chen S; Dong Q; Hu S; Cai J; Zhang W; Sun J; Wang T; Xie J; He H; Xing J; Lu J; Dong Y
Mol Biosyst; 2014 Feb; 10(2):294-303. PubMed ID: 24292090
[TBL] [Abstract][Full Text] [Related]
2. Paeonol reverses paclitaxel resistance in human breast cancer cells by regulating the expression of transgelin 2.
Cai J; Chen S; Zhang W; Hu S; Lu J; Xing J; Dong Y
Phytomedicine; 2014 Jun; 21(7):984-91. PubMed ID: 24680370
[TBL] [Abstract][Full Text] [Related]
3. Salvianolic acid A reverses the paclitaxel resistance and inhibits the migration and invasion abilities of human breast cancer cells by inactivating transgelin 2.
Zheng X; Chen S; Yang Q; Cai J; Zhang W; You H; Xing J; Dong Y
Cancer Biol Ther; 2015; 16(9):1407-14. PubMed ID: 26176734
[TBL] [Abstract][Full Text] [Related]
4. Proteomic identification of differentially expressed proteins associated with the multiple drug resistance in methotrexate-resistant human breast cancer cells.
Chen S; Cai J; Zhang W; Zheng X; Hu S; Lu J; Xing J; Dong Y
Int J Oncol; 2014 Jul; 45(1):448-58. PubMed ID: 24736981
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel resistance in MCF-7/PTX cells is reversed by paeonol through suppression of the SET/phosphatidylinositol 3-kinase/Akt pathway.
Zhang W; Cai J; Chen S; Zheng X; Hu S; Dong W; Lu J; Xing J; Dong Y
Mol Med Rep; 2015 Jul; 12(1):1506-14. PubMed ID: 25760096
[TBL] [Abstract][Full Text] [Related]
6. Salvianolic acid A reverses paclitaxel resistance in human breast cancer MCF-7 cells via targeting the expression of transgelin 2 and attenuating PI3 K/Akt pathway.
Cai J; Chen S; Zhang W; Zheng X; Hu S; Pang C; Lu J; Xing J; Dong Y
Phytomedicine; 2014 Oct; 21(12):1725-32. PubMed ID: 25442283
[TBL] [Abstract][Full Text] [Related]
7. Bioreducible and acid-labile polydiethylenetriamines with sequential degradability for efficient transgelin-2 siRNA delivery.
Wang P; Yan Y; Sun Y; Zhang R; Huo C; Li L; Wang K; Dong Y; Xing J
J Mater Chem B; 2019 Nov; 7(44):6994-7005. PubMed ID: 31625545
[TBL] [Abstract][Full Text] [Related]
8. SET protein overexpression contributes to paclitaxel resistance in MCF-7/S cells through PI3K/Akt pathway.
Zhang W; Zheng X; Meng T; You H; Dong Y; Xing J; Chen S
J Drug Target; 2017 Mar; 25(3):255-263. PubMed ID: 27718638
[TBL] [Abstract][Full Text] [Related]
9. Establishment of paclitaxel-resistant breast cancer cell line and nude mice models, and underlying multidrug resistance mechanisms in vitro and in vivo.
Chen SY; Hu SS; Dong Q; Cai JX; Zhang WP; Sun JY; Wang TT; Xie J; He HR; Xing JF; Lu J; Dong YL
Asian Pac J Cancer Prev; 2013; 14(10):6135-40. PubMed ID: 24289639
[TBL] [Abstract][Full Text] [Related]
10. Differentially expressed proteins in human MCF-7 breast cancer cells sensitive and resistant to paclitaxel.
Pavlíková N; Bartoňová I; Balušíková K; Kopperova D; Halada P; Kovář J
Exp Cell Res; 2015 Apr; 333(1):1-10. PubMed ID: 25557873
[TBL] [Abstract][Full Text] [Related]
11. [Proteomic analysis of paclitaxel-induced apoptosis in MCF-7 human breast carcinoma cells].
Wu F; Wang QM; Fan GC; Chen JZ; Chen HP
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):418-21. PubMed ID: 17152485
[TBL] [Abstract][Full Text] [Related]
12. Comparative proteomic analysis of paclitaxel sensitive A549 lung adenocarcinoma cell line and its resistant counterpart A549-Taxol.
Sun QL; Sha HF; Yang XH; Bao GL; Lu J; Xie YY
J Cancer Res Clin Oncol; 2011 Mar; 137(3):521-32. PubMed ID: 20499251
[TBL] [Abstract][Full Text] [Related]
13. Differentially Expressed Mitochondrial Proteins in Human MCF7 Breast Cancer Cells Resistant to Paclitaxel.
Daniel P; Halada P; Jelínek M; Balušíková K; Kovář J
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31248089
[TBL] [Abstract][Full Text] [Related]
14. Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs.
Chuthapisith S; Layfield R; Kerr ID; Hughes C; Eremin O
Int J Oncol; 2007 Jun; 30(6):1545-51. PubMed ID: 17487377
[TBL] [Abstract][Full Text] [Related]
15. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
[TBL] [Abstract][Full Text] [Related]
16. Comparative proteomic analysis of paclitaxel resistance-related proteins in human breast cancer cell lines.
Fujioka H; Sakai A; Tanaka S; Kimura K; Miyamoto A; Iwamoto M; Uchiyama K
Oncol Lett; 2017 Jan; 13(1):289-295. PubMed ID: 28123557
[TBL] [Abstract][Full Text] [Related]
17. Differentially expressed proteins in human breast cancer cells sensitive and resistant to paclitaxel.
Pavlikova N; Bartonova I; Dincakova L; Halada P; Kovar J
Int J Oncol; 2014 Aug; 45(2):822-30. PubMed ID: 24898082
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells.
Lee KH; Yim EK; Kim CJ; Namkoong SE; Um SJ; Park JS
Gynecol Oncol; 2005 Jul; 98(1):45-53. PubMed ID: 15907983
[TBL] [Abstract][Full Text] [Related]
19. Drug resistant breast cancer cells overexpress ETS1 gene.
Kars MD; Işeri OD; Gündüz U
Biomed Pharmacother; 2010 Sep; 64(7):458-62. PubMed ID: 20392592
[TBL] [Abstract][Full Text] [Related]
20. LINC00160 mediated paclitaxel-And doxorubicin-resistance in breast cancer cells by regulating TFF3 via transcription factor C/EBPβ.
Wu H; Gu J; Zhou D; Cheng W; Wang Y; Wang Q; Wang X
J Cell Mol Med; 2020 Aug; 24(15):8589-8602. PubMed ID: 32652877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
